Type 2 diabetes mellitus (T2DM) is an increasing global public health problem, and its
prevalence is expected to rise in coming decades. Dipeptidyl peptidase-4 (DPP-4) is a …

Background The clinical spectrum of stiff-person syndrome (SPS) encompasses a wide
range of signs including psychiatric symptoms (PS). Objective Our objective was to provide …

DPP-4Is are well recognized therapy for type 2 diabetes. In spite of sharing a common mode
of action, the chemical diversity among members of DPP‐4Is raised the question whether …

Background: Delirium is a common geriatric syndrome, with a prevalence of between 15–
70% among older long-term care residents. It is associated with adverse outcomes, and its …

Background: Depressive disorders are more common in patients with diabetes mellitus (DM)
compared to the general population. Objectives: Due to heterogeneous evidence on the …

To compare the potential role of sodium-glucose cotransporter-2 inhibitors (SGLT2I) in the
development of psychiatric disease among patients with type 2 diabetes mellitus (DM) …

Diabetes mellitus (DM) is not a single disease, but a group of diseases that are
characterized by chronic hyperglycemia associated with impaired secretion or activity of …

Background Liver biomarkers alanine aminotransferase (ALT) and bilirubin in patients with
hepatitis are above the healthy volunteer reference range (HVRR) at baseline (prior to …

Background Many epidemiological studies have investigated the prevalence of type 2
diabetes in individuals with a psychiatric disorder. In an umbrella review, we aim to …

Pacientes esquizofrênicos possuem marcadores elevados de inflamação, sabe-se também
que a inflamação piora o curso da doença e induz aumento de níveis séricos de clozapina …